| Company name | Ticker | Asset type | Sector | Market cap | % in ETF |
|---|---|---|---|---|---|
| ILMN | Stock | Healthcare | US$ 41.23 B | 2,54% | |
| KEYS | Stock | Technology | US$ 54.92 B | 1,99% | |
| MRK | Stock | Healthcare | US$ 370.89 B | 1,75% | |
Standard Chartered PLC
|
STAN | Stock | Financial | US$ 47.65 B | 1,51% |
| BIIB | Stock | Healthcare | US$ 32.63 B | 1,50% | |
| JNJ | Stock | Healthcare | US$ 663.28 B | 1,44% | |
| PFG | Stock | Financial | US$ 25.37 B | 1,35% | |
SSE PLC
|
SSE | Stock | Utilities | US$ 29.73 B | 1,35% |
Welltower Inc
|
WELL | Stock | Real Estate | US$ 170.18 B | 1,34% |
Swedbank AB (publ)
|
SWED-A | Stock | Financial | US$ 454.21 B | 1,32% |
| CM | Stock | Financial | US$ 100.80 B | 1,32% | |
| VOD | Stock | Communication Services | US$ 38.97 B | 1,31% | |
| GM | Stock | Consumer Cyclical | US$ 78.89 B | 1,31% | |
| MAR | Stock | Consumer Cyclical | US$ 87.64 B | 1,28% | |
National Bank of Canada
|
NA | Stock | Financial | US$ 51.07 M | 1,27% |
|
NN Group NV
|
NN | Stock | Financial | US$ 2.36 B | 1,26% |
| IFF | Stock | Basic Materials | US$ 22.03 B | 1,25% | |
| C | Stock | Financial | US$ 231.02 B | 1,23% | |
Iberdrola S.A.
|
IBE | Stock | Utilities | US$ 138.93 B | 1,22% |
| EIX | Stock | Utilities | US$ 21.85 B | 1,20% | |
The Royal Bank of Scotland Group plc
|
RBS | Stock | Regional Banks | US$ 14.66 B | 1,20% |
Storebrand ASA
|
STB | Stock | Financial | US$ 80.13 B | 1,20% |
| AA | Stock | Basic Materials | US$ 11.07 B | 1,19% | |
| SU | Stock | Industrials | US$ 82.13 B | 1,17% | |
| GSK | Stock | Healthcare | US$ 94.23 B | 1,16% | |
| ENG | Stock | Utilities | US$ 4.34 B | 1,14% | |
|
Takeda Pharmaceutical Co. Ltd.
|
4502 | - | Healthcare | - | 1,14% |
QBE Insurance Group Limited
|
QBE | Stock | Financial | US$ 35.57 B | 1,13% |
| NOVN | Stock | Healthcare | US$ 221.13 B | 1,12% | |
UBS Group AG
|
UBSG | Stock | Financial | US$ 121.03 B | 1,12% |
| EXPE | Stock | Consumer Cyclical | US$ 36.38 B | 1,12% | |
| HLT | Stock | Consumer Cyclical | US$ 70.75 B | 1,12% | |
| HAS | Stock | Consumer Cyclical | US$ 13.12 B | 1,12% | |
Yara International ASA
|
YAR | Stock | Basic Materials | US$ 105.76 B | 1,12% |
| ALV | Stock | Financial | US$ 8.19 B | 1,11% | |
| ETSY | Stock | Consumer Cyclical | US$ 6.68 B | 1,11% | |
Jones Lang LaSalle Incorporated
|
JLL | Stock | Real Estate | US$ 16.67 B | 1,10% |
| SJM | Stock | Services | US$ 13.73 B | 1,09% | |
| DOW | Stock | Basic Materials | US$ 21.93 B | 1,07% | |
| RL | Stock | Consumer Cyclical | US$ 20.93 B | 1,07% | |
Publicis Groupe SA
|
PUB | Stock | Communication Services | US$ 24.35 B | 1,05% |
Wex Inc
|
WEX | Stock | Technology | US$ 6.61 B | 1,03% |
| JPM | Stock | Financial | US$ 953.33 B | 1,02% | |
|
WFD Unibail Rodamco NV
|
URW | - | Real Estate | - | 1,02% |
Enel SpA
|
ENEL | Stock | Utilities | US$ 87.29 B | 1,01% |
| NYT | Stock | Communication Services | US$ 10.11 B | 1,01% | |
| ORA | Stock | Communication Services | US$ 6.48 B | 1,01% | |
| CL | Stock | Services | US$ 70.77 B | 1,01% | |
| ADM | Stock | Financial | US$ 40.78 B | 1,01% | |
| F | Stock | Consumer Cyclical | US$ 57.46 B | 1,00% | |
| AZN | Stock | Healthcare | US$ 243.34 B | 1,00% | |
| VZ | Stock | Communication Services | US$ 210.19 B | 1,00% | |
National Grid PLC
|
NG | Stock | Utilities | US$ 2.87 B | 0,99% |
| SW | Stock | Industrials | US$ 22.31 B | 0,98% |
Average Investor10 user rating
4.0
(0 people)
UBS (Irl) ETF Public Limited Company - Global Gender Equality UCITS ETF (Ireland) is an exchange-traded fund (ETF), with assets under management totaling $76.38 million.
Over the past 12 months, UBS (Irl) ETF Public Limited Company - Global Gender Equality UCITS ETF recorded a return of 8.39%, with its price trading between $0.34 and $27.70 during the same period.
The ETF is traded under the ticker GENE.
The current price of GENE is $25.68. You can track the real-time price chart, review historical performance, and access detailed information about this ETF on the platform.
GENE is currently trading at $25.68, with a market capitalization of approximately $76.380.305,00. Over the past year, the ETF has delivered a 8.39% return, based on share price performance.
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
You can invest in GENE through a brokerage account that provides access to the exchange where it is listed. After opening and funding your account, search for the ticker symbol GENE, select the number of shares you wish to purchase, and place your order.
In certain markets, similar exposure may also be available through locally listed products that track the same index.
Over the past month, GENE has returned -4.62%, and 8.39% over the past year.
If you were to purchase 100 shares of GENE at the current price of $25.68, your total investment would be $2,568.00.
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
Sign in with your social account or email
Create your account
Already have an account? Login
Tesla
Dividend Schedule
Ranking of Stocks
Ranking of Brazilian ETFs
Crypto Rankings
